文献速递脑血管病

不明来源栓塞性卒中患者的心房病变研究

Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies.
PubMed 文献 · Neurology · 2018-12-05

这项横断面研究纳入846例连续缺血性卒中患者,比较不明来源栓塞性卒中(ESUS)与其他病因卒中患者的心房病变患病率。结果显示ESUS患者心房病变患病率为26.6%,高于大动脉粥样硬化性卒中的12.1%和小血管病卒中的16.9%(p=0.001)。ESUS患者临床特征与心源性栓塞患者不同,心房病变可能反映独特的血栓栓塞机制,但抗凝获益尚不明确。

要点

  • ESUS患者心房病变患病率26.6%,高于LAA的12.1%和SVD的16.9%(p=0.001)。
  • ESUS患者较心源性栓塞患者更年轻、高血压更少、胆固醇更高。
  • 心房病变能否指导ESUS抗凝或预测复发尚不明确。

核心结论

  • ESUS患者心房病变患病率高于非栓塞性卒中患者,且临床特征与心源性栓塞患者不同。

研究设计与样本

  • 横断面研究纳入846例连续缺血性卒中患者,比较ESUS与其他病因卒中的心房病变患病率。

主要发现

  • 158例(19%)符合ESUS诊断标准,LAA 224例(26%),SVD 154例(18%),CE 310例(37%)。
  • 心房病变患病率在ESUS为26.6%,LAA为12.1%,SVD为16.9%(p=0.001)。
  • ESUS患者较CE患者更年轻、高血压更少、胆固醇和低密度脂蛋白更高,但左心室或心房异常更少。

关键数值与推荐

  • 心房病变定义为V1导联P波终末力>5,000 µV·ms或重度左心房扩大。

临床怎么用

  • ESUS患者应评估心房病变,但其是否指导抗凝治疗或风险分层尚需进一步研究。

局限性

  • 横断面设计无法确定因果关系,心房病变与卒中复发的关联未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the prevalence and clinical determinants of atrial cardiopathy in patients with embolic stroke of unknown source (ESUS) and compare with other established stroke etiologies. METHODS: In a cross-sectional study of 846 consecutive patients with ischemic stroke, we compared the prevalence of atrial cardiopathy (defined by p-wave terminal force in V1 >5,000 µV·ms or severe left atrial enlargement) between ESUS patients and patients with large artery atherosclerosis (LAA) and small vessel disease (SVD) strokes. Baseline characteristics were also compared between ESUS and cardioembolic (CE) patients. RESULTS: Of all, 158 (19%) patients met ESUS diagnostic criteria, while others were classified into LAA (n = 224, 26%), SVD (n = 154, 18%), and CE (n = 310, 37%). The prevalence of atrial cardiopathy was higher in ESUS patients compared to noncardioembolic stroke patients (26.6% vs 12.1% in LAA vs 16.9% in SVD; p = 0.001). ESUS patients were younger, were less hypertensive, and had higher cholesterol and low-density lipoprotein levels, but also had less left ventricular or atrial abnormalities when compared to CE patients. CONCLUSION: The prevalence of atrial cardiopathy was high in ESUS patients compared with patients with nonembolic strokes. Interestingly, ESUS patients were also clinically different from CE patients. While the presence of atrial cardiopathy may reflect a unique mechanism of thromboembolism in ESUS patients, it is still unclear if they may benefit from anticoagulation, or if the presence of atrial cardiopathy in this population could serve as a risk-stratifying marker for stroke recurrence. Further efforts are necessary to provide better characterization of the ESUS population in order to develop better stroke preventive strategies.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Jalini S, Rajalingam R, Nisenbaum R, et al. Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies. Neurology. 2018. PMID: 30518556. doi:10.1212/WNL.0000000000006748

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。